Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Phytopharm's loss grew to 4.6 million euros

Article Abstract:

Phytopharm PLC posted a higher pretax loss for the year ending August 31, 2001. The company posted 2.9 million pounds (4.6 million euros) in pretax losses for the period, compared to 2.2 million pounds in the same 2000 period.

Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
Phytopharm PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Bioglan's wrangling may be tied to deal

Article Abstract:

Bioglan Pharma PLC is due to post its first-half results, but has experienced difficulty lately. The pharmaceutical firm's shares fell nearly 30% in a day last month.

Author: Rodgers, Susannah
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
Abstract, Bioglan Pharma PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United Kingdom, Pharmaceutical industry, Drugs, Finance
Similar abstracts:
  • Abstracts: SkyePharma's loss widened in first half. Oxford loss widened in half. Shire's earnings rise 66%, topping estimates
  • Abstracts: Allied Zurich looks with confidence to second half. Zurich's net may drop by up to 28%
  • Abstracts: Clariant's sales beat forecasts in first half. Credit Suisse Group posts loss, plans to cut jobs and dividend
  • Abstracts: Targets of takeover talk. Nation's three biggest banks to consolidate operations. Japan takes cautious stand on U.S. retaliation
  • Abstracts: Unlease corporate sector instead of printing yen. Japan builds on ruins of old system
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.